Skip to main content
Clinical Trials/CTRI/2016/10/007412
CTRI/2016/10/007412RecruitingPhase 4

To Compare Efficacy and Safety of Levetiracetam with Phenobarbitone in Neonates with Perinatal Asphyxia: A Randomized Controlled Trial - LeveNeo Trial

Sarojini Naidu Children Hospital0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Full term neonates (37 completed weeks to less than 42 weeks of gestational age)
  • Less than 24 hours of age at presentation
  • HIE stage II or III (as per Sarnat and Sarnat staging)

Exclusion Criteria

  • Neonates received at least one dose of anticonvulsants
  • Severe congenital anomalies or CNS malformations
  • Convulsions due to hypoglycemia/hypocalcemia
  • Neonatal Sepsis
  • Major intracranial hemorrhage
  • Serum creatinine more than 0.8 mg/dl

Investigators

Sponsor
Sarojini Naidu Children Hospital

Similar Trials